View in EDS HTML Full Text PDF Full Text

Early Use of Remdesivir and Convalescent Plasma Reduces COVID-19 Mortality in Patients with Hematologic Malignancies.

Saved in:
Bibliographic Details
Title: Early Use of Remdesivir and Convalescent Plasma Reduces COVID-19 Mortality in Patients with Hematologic Malignancies.
Authors: Valković, Toni1,2,3 (AUTHOR), Bašić-Kinda, Sandra2,4 (AUTHOR), Grubešić, Aron3,5,6 (AUTHOR), Stanić Damić, Marija4,5,6 (AUTHOR), Jakšić, Ozren5,7,8 (AUTHOR), Mrđenović, Stefan6,9,10 (AUTHOR), Novaković-Coha, Sabina7,11 (AUTHOR), Lozić, Dominik8,12 (AUTHOR), Mikulić, Mirta4,9 (AUTHOR), Serventi Seiwerth, Ranka4,10 (AUTHOR), Dujmović, Dino4,11 (AUTHOR), Dreta, Barbara4,12 (AUTHOR), Pavliša, Gordana8,13 (AUTHOR), Narančić, Marino1,4 (AUTHOR), Hude-Dragičević, Ida2,4 (AUTHOR), Aurer, Igor3,4,8 (AUTHOR)
Source: COVID. Jun2026, Vol. 6 Issue 6, p96. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:26738112
DOI:10.3390/covid6060096